A randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of Fufang Danshen (Salvia miltiorrhiza) as add-on antihypertensive therapy in Taiwanese patients with uncontrolled hypertension

Phytotherapy Research

Volumn 26, Issue 2, 2012, Pages 291-298

  Yang, Tsung Yuan ^a   Wei, James Cheng Chung ^b   Lee, Ming Yung ^c   Chen, C M Balance ^d   Ueng, Kwo Chang ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c PROVIDENCE UNIVERSITY   (Taiwan)

^d Salvia Medical Research Center   (Taiwan)

Author keywords

Fufang Danshen; hypertension; Salvia miltiorrhiza

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; SALVIA MILTIORRHIZA EXTRACT;

ADD ON THERAPY; ADULT; AGED; ALOPECIA; ARTICLE; BLOOD PRESSURE REGULATION; BLURRED VISION; COMMON COLD; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE CONTROL; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; DYSURIA; ETHNIC GROUP; FACE FLUSHING; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEART PALPITATION; HUMAN; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PHOTODERMATOSIS; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SORE THROAT; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TAIWANESE; TREATMENT RESPONSE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SALVIA MILTIORRHIZA;

ANIMALIA; SALVIA MILTIORRHIZA;

EID: 84856303906     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3548     Document Type: Article

References (31)

1. Campbell WB, Falck JR,. 2007. Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors. Hypertension 49: 590-596. Epub 2007 Jan 2.
2. Chan P, Liu IM, Li YX, et al,. 2009. Antihypertension induced by tanshinone IIA isolated from the roots of Salvia miltiorrhiza. eCAM Adv Access published June 19, 2009. Page 1 of 8 doi: 10.1093/ecam/nep056
3. Cheng TO,. 2007. Cardiovascular effects of Danshen. Int J Cardiol 121: 9-22. Epub 2007 Mar 23. (Pubitemid 47287779)
4. Chobanian AV, Bakris GL, Black HR, et al,. 2003. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC7 report. J Am Med Assoc 289: 2560-2571.
5. Dahlof B, Sever PS, Poulter NR, et al,. 2005. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 366 (9489): 895-906. (Pubitemid 41265663)
6. Elliott WJ,. 2003. The economic impact of hypertension. J Clin Hypertens 5: 3-13.
7. Izzo AA, Di Carlo G, Borelli F, Ernst E,. 2005. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol 98: 1-14. (Pubitemid 40169845)
8. Kim DD, Sanchez FA, Duran RG, Kanetaka T, Duran WN,. 2007. Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. Am J Physiol Heart Circ Physiol 292: H2131-H2137. (Pubitemid 47084591)
9. Kwan YW, To KW, Lau WM, Tsang SH,. 1999. Comparison of the vascular relaxant effects of ATP-dependent Kt channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats. Eur J Pharmacol 365: 241-251. (Pubitemid 29070770)
10. Lam FF, Yeung JH, Cheng JHY, Or PMY,. 2006. Pharmacological evidence for calcium channel inhibition by danshen (Salvia miltiorrhiza) on rat isolated femoral artery. J Cardiovasc Pharmacol 47: 139-145. (Pubitemid 44378237)
11. Li YG, Song L, Liu M, Hu ZB, Wang ZT,. 2009. Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen). J Chromatogr A 1216: 1941-1953. Epub 2008 Dec 24.
12. Lu FH, Tang SJ, Wu JS, Yang YC, Chang CJ,. 2000. Hypertension in elderly persons: its prevalence and associated cardiovascular risk factors in Tainan City, southern Taiwan. J Gerontol A Biol Sci Med Sci 55: M463-M468.
13. Mancia G, De Backer G, Dominiczak A, et al,. 2007. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25: 1105-1187. (Pubitemid 46924065)
14. Ren ZH, Tong YH, Xu W, Ma J, Chen Y,. 2009. Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression. Phytomedicine 17: 212-218. Epub 2009 Oct 2.
15. Sierra C, Lõpez-Soto A, Coca A, et al,. 2008. Hypertension in the elderly population. Rev Esp Geriatr Gerontol 43 (Suppl 2): 53-59.
16. Su TC, Hwang LC, You SL, Chen CJ,. 2008. Ethnic variation in hypertension prevalence of women in Taiwan Ethnic variation of hypertension in Taiwanese women. J Hum Hypertens 23: 160-167. Epub 2008 Oct 2.
17. Swislocki A, Noth RH, Volpp B, Meier J, Siegel D,. 2006. Blood pressure control in a diabetic population assessed by computer review. J Hum Hypertens 20: 540-542. Epub 2006 Mar 16. (Pubitemid 43923126)
18. Tang F, Wu X, Wang T, et al,. 2007. Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vasc Pharmacol 46: 427-438. Epub 2007 Jan 23. (Pubitemid 46552282)
19. Teramoto N,. 2006. Physiological roles of ATP-sensitive Kt channels in smooth muscle. J Physiol 572: 617-624.
20. Tobe S, Kawecka-Jaszcz K, Zannad F, Vetrovec G, Patni R, Shi H,. 2007. Amlodipine added to quinapril vs quinapril alone for the treatment of hypertension in diabetes: the Amlodipine in Diabetes (ANDI) Trial. J Clin Hypertens 9: 120-127.
21. Wang AM, Sha SH, Lesniak W, Schacht J,. 2003. Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and cytotoxicity in vivo. Antimicrob Agents Chemother 47: 1836-1841. (Pubitemid 36637803)
22. Wang SP, Zang WJ, Kong SS, et al,. 2008. Vasorelaxant effect of isopropyl 3-(3, 4-dihydroxyphenyl)-2-hydroxypropanoate, a novel metabolite from Salvia miltiorrhiza, on isolated rat mesenteric artery. Eur J Pharmacol 579: 283-288.
23. Wolf-Maier K, Cooper RS, Kramer H, et al,. 2004. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43: 10-17. (Pubitemid 38031904)
24. World Health Organization/ International Society of Hypertension Writing Group. 2003. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC7 report. J Am Med Assoc 21: 1983-1992.
25. Wu B, Liu M, Zhang S,. 2004. Dan Shen agents for acute ischaemic stroke. Cochrane Database Syst Rev 18 (4): CD004295.
26. A elicited vasodilation in rat coronary arteriole: Roles of nitric oxide and potassium channels. Eur J Pharmacol 617: 102-107. Epub 2009 Jul 1.
27. Wu WW, Yeung JH,. 2010. Inhibition of warfarin hydroxylation by major tanshinones of Danshen (Salvia miltiorrhiza) in the rat in vitro and in vivo. Phytomedicine 17: 219-226. Epub 2009 Jul 3.
28. Xu G, Zhao W, Zhou Z, Zhang R, Zhu W, Liu X,. 2009. Danshen extracts decrease blood C reactive protein and prevent ischemic stroke recurrence: a controlled pilot study. Phytother Res 23: 1721-1725.
29. Yang L, Zou X, Liang Q, et al,. 2007. Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway. Exp Mol Med 39: 65-73. (Pubitemid 46356007)
30. Yang Y, Cai F, Li PY, et al,. 2008. Activation of high conductance Ca2+-activated K+channels by sodium tanshinoneII-A sulfonate (DS-201) in porcine coronary artery smooth muscle cells. Eur J Pharmacol 598: 9-15.
31. Zhou L, Zuo Z, Chow MS,. 2005. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45: 1345-1359. (Pubitemid 41643896)